Gorman Rupp Co (GRC) · Oct 23, 2026 · Earnings
Beat — EPS $0.86 vs ~$0.70 consensus; revenue $193.3M vs ~$181.6M
Gorman-Rupp’s third-quarter earnings beat expectations, with record sales, sharply higher margins, stronger cash flow, and $58 million of debt reduction.
Gorman-Rupp is a diversified pump manufacturer serving water, wastewater, construction, agriculture, industrial, HVAC, petroleum, and fire-suppression markets, with Fill-Rite adding liquid-transfer products across agriculture and construction. The current growth story is broadening demand in construction, agriculture, and industrial applications rather than dependence on one end market.
The quarter beat on both major scorecard lines. Third-quarter EPS of $0.86 exceeded the published consensus of roughly $0.70, while revenue of $193.3 million topped roughly $181.6 million; the filing also says sales rose across all markets. The result is meaningfully ahead of what investors had been positioned for, not merely another in-line quarter.
| Metric | Q3 2026 | Q3 2025 | Expectation / comparison |
|---|---|---|---|
| Net sales | $193.3M (Income Statement) | $172.8M (Income Statement) | ~$181.6M published consensus |
| EPS | $0.86 (Income Statement) | $0.43 (Income Statement) | ~$0.70 published consensus |
| Gross margin | 33.4% (Financial Highlights) | 29.2% (Financial Highlights) | Up 420 bps year over year |
| Operating margin | 17.5% (Financial Highlights) | 12.4% (Financial Highlights) | Up 510 bps year over year |
| Adjusted EBITDA | $41.8M (Financial Highlights) | $32.3M (Financial Highlights) | Up 29.4% year over year |
| Nine-month incoming orders | $562.2M (Operating Update) | $550.2M implied by filing comparison | Up 2.2% year over year |
| September 30 backlog | $236.8M (Operating Update) | $234.2M | Below $244.0M at December 31, 2025 |
Margin expansion is the most important upgrade to the business story. Gross margin reached 33.4%, and operating margin reached 17.5%, helped by volume leverage, lower LIFO expense, better medical costs, and the absence of last year’s facility-optimization charges. The improvement is therefore not entirely recurring, but the operating leverage from higher volume and better SG&A absorption appears genuine.
Cash generation is turning earnings into balance-sheet repair. Operating cash flow reached $114.9 million through nine months, while total debt fell by $58.0 million and interest expense declined. That reduces financial drag and gives the company more room to keep investing without relying on additional borrowing.
Demand is healthy but not accelerating as fast as profits. Nine-month orders rose only 2.2%, and backlog is modestly above last year but below year-end 2025. That makes the earnings beat more impressive, but it also means the company still needs continued pricing, mix, and productivity gains to sustain the current profit rate.
Bottom line: This was a genuine beat that advances Gorman-Rupp’s story from recovery toward stronger, more profitable execution. The main qualification is that order growth remains modest and part of the margin jump reflects costs that disappeared from last year’s comparison.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!